LUMECCA
Lumecca is a breakthrough intense pulsed light (IPL) that delivers up to 3X more energy in the 500-600 nm range to improve efficacy for vascular and pigmented lesions. It is optimized for clinicians to treat a variety of lesions with fewer sessions.
KEY BENEFITS:
- High efficiency of treatment due to high peak power and optimized output.
- Complete photo rejuvenation in 1 or 2 treatments for most patients versus 4-6 treatments with standard IPL’s. deeper tissue treatments.
- Reduces treatment time thanks to large spot size and high pulse repetition rate.
- Strong sapphire cooling tip results in higher treatment comfort.
VASCULAR LESIONS
Lumecca can reduce vascular lesions, including port wine stains, facial, truncal and leg telangiectasias, rosacea, erythema of rosacea, angiomas and spider angiomas, poikilodenna of Civatte, superficial leg veins and venous malformations.
PIGMENTATION
Use the power of Lumecca to effectively treat benign pigmented epidermal lesions, including dyschromia, hyperpigmentation, and ephelides (freckles).




MORPHEUS8
Morpheus8 is a safe and effective minimally invasive modular RF fractional solution for full body subdermal adipose remodeling.
KEY BENEFITS
- Morpheus8 delivers the deepest fractional treatments available, penetrating subdermal tissue up to 8mm (7mm + 1mm thermal profile).
- Dual Handpieces allow for increased treatment functionality:
- Morpheus8 for smaller treatment areas and Morpheus8 Body for larger and deeper tissue treatments.
- Four fractional tips with different microneedle configurations (Prime 12 pin, Resurfacing 24 pin, Morpheus8 24 pin, and Body 40 pin) deliver clinically proven RF energy to multiple treatment depths (0.5mm – 7mm).
- Equipped with Burst mode RF technology, Morpheus8 Body automatically deploys bipolar RF energy to multi-level treatment depths in a single cycle. The ability to target tissue sequentially at three levels, in millisecond intervals, allows for a significant reduction in treatment times, minimizes skin injury, increases treatment uniformity, and enables customized full body fractional procedures.
FACE AND BODY
- Morpheus8 targets subdermal layers of the skin and tissue to remodel collagen on the face and body.
- Safe on skin types up to and including VI with little risk of post inflammatory hyperpigmentation (PIH) which is common with other resurfacing methods.
COLAGEN
This fractional tissue treatment simulates the production of collagen in the underlying layers of the dermis. Morpheus8’s modular tips enable procedures to be customized for large or small body areas.






FILLER
We use the Belotero brand, a hyaluronic acid dermal filler made with the same volumizing and hydrating component as the skin, making it the best natural choice for your face.
Additionally, it contains lidocaine, an anesthetic that reduces pain and facilitates the treatment, perfect for preventing and treating signs of facial aging, hydrating the skin, lip augmentation, reshaping, and restoring facial volume, among others.
We offer a range of Belotero fillers, depending on the area you wish to target.




BOTOX
We use the most natural botulinum toxin on the market to provide you with natural and long-lasting results.
Xeomin eliminates expression lines on the forehead, commonly known as "frown lines."
It also addresses crow's feet or lines around the eyes and forehead. When used in combination in these areas, it can result in a natural brow lift. Like other products, it also has more advanced applications, such as reducing chin wrinkles, lifting the corner of the mouth while avoiding a sad expression, among many others.


BODYTITE
Body reshaping treatment in large areas such as the abdomen, legs, or flanks that reduces localized fat and body sagging, also known as "non-surgical liposuction." It involves minimally invasive radiofrequency-assisted lipolysis with surgical-like results but without scars and minimal postoperative recovery.
In just one session, you can achieve 100% of the fat elimination results and approximately 50% of skin retraction, improving further over the first 6 months.





